These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31236580)

  • 21. Factors influencing the EULAR Sjögren's Syndrome Patient-Reported Index in primary Sjögren's syndrome.
    Sandoval-Flores MG; Chan-Campos I; Hernández-Molina G
    Clin Exp Rheumatol; 2021; 39 Suppl 133(6):153-158. PubMed ID: 34128801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of total glucosides of peony in the treatment of primary Sjögren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial.
    Liu X; Li X; Li X; Li Z; Zhao D; Liu S; Zhang M; Zhang F; Zhu P; Chen J; Wei W; Lin B; Zhou Y; Chen J; Pang Y; Zhang L; Sun X; Yu Z; Jia Y; Wang J; Sun W; Chiu F; Pang L; Wang G
    Clin Rheumatol; 2019 Mar; 38(3):657-664. PubMed ID: 30280368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry.
    Dumusc A; Ng WF; James K; Griffiths B; Price E; Pease C; Emery P; Lanyon P; Jones A; Bombardieri M; Sutcliffe N; Pitzalis C; Gupta M; McLaren J; Cooper A; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Barone F; Fisher B; Rauz S; Richards A; Bowman S
    Swiss Med Wkly; 2018; 148():w14588. PubMed ID: 29442344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of sleep quality on clinical features of primary Sjögren's syndrome.
    Chung SW; Hur J; Ha YJ; Kang EH; Hyon JY; Lee HJ; Song YW; Lee YJ
    Korean J Intern Med; 2019 Sep; 34(5):1154-1164. PubMed ID: 29458245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.
    Mandl T; Marsal J; Olsson P; Ohlsson B; Andréasson K
    Arthritis Res Ther; 2017 Oct; 19(1):237. PubMed ID: 29065905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pain and fatigue are predictors of quality of life in primary Sjögren's syndrome.
    Dias LH; Miyamoto ST; Giovelli RA; de Magalhães CIM; Valim V
    Adv Rheumatol; 2021 May; 61(1):28. PubMed ID: 34051867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant fibromyalgia in primary Sjögren's syndrome in the French ASSESS cohort: comparison of the ACR 1990 and ACR 2016 criteria, FiRST questionnaire and physician's opinion.
    Dubost JJ; Couderc M; Pereira B; Mariette X; Seror R; Gottenberg JE; Hachulla E; Le Guern V; Saraux A; Morel J; Salliot C; Tournadre A; Soubrier M
    Clin Exp Rheumatol; 2021; 39 Suppl 133(6):140-145. PubMed ID: 34919043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
    Milic V; Colic J; Cirkovic A; Stanojlovic S; Damjanov N
    PLoS One; 2019; 14(12):e0226498. PubMed ID: 31891590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic interferon type I and type II signatures in primary Sjögren's syndrome reveal differences in biological disease activity.
    Bodewes ILA; Al-Ali S; van Helden-Meeuwsen CG; Maria NI; Tarn J; Lendrem DW; Schreurs MWJ; Steenwijk EC; van Daele PLA; Both T; Bowman SJ; Griffiths B; Ng WF; ; Versnel MA
    Rheumatology (Oxford); 2018 May; 57(5):921-930. PubMed ID: 29474655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Rituximab Originator With CT-P10 Biosimilar in Patients With Primary Sjögren's Syndrome: A Retrospective Analysis in a Real-Life Setting.
    Pavlych V; Di Muzio C; Alunno A; Carubbi F
    Front Med (Lausanne); 2020; 7():534. PubMed ID: 33015092
    [No Abstract]   [Full Text] [Related]  

  • 31. Acupuncture for Primary Sjögren Syndrome (pSS) on symptomatic improvements: study protocol for a randomized controlled trial.
    Jiang Q; Zhang H; Pang R; Chen J; Liu Z; Zhou X
    BMC Complement Altern Med; 2017 Jan; 17(1):61. PubMed ID: 28103850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of systemic activity of pediatric primary Sjögren's syndrome by EULAR Sjögren's syndrome disease activity index (ESSDAI).
    Kobayashi I; Okura Y; Ueki M; Tozawa Y; Takezaki S; Yamada M; Ariga T
    Mod Rheumatol; 2019 Jan; 29(1):130-133. PubMed ID: 29529894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resilience in women with primary Sjögren's syndrome.
    Priori R; Giardina F; Izzo R; Gattamelata A; Fusconi M; Colafrancesco S; Curcio G
    Rheumatol Int; 2021 Nov; 41(11):1987-1994. PubMed ID: 34091740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical determinants of vaginal dryness in patients with primary Sjögren's syndrome.
    Farenhorst CA; de Wolff L; Arends S; van Nimwegen JF; Kroese FGM; Verstappen GM; Bootsma H
    Clin Exp Rheumatol; 2021; 39 Suppl 133(6):73-79. PubMed ID: 34665706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progenitor cell niche senescence reflects pathology of the parotid salivary gland in primary Sjögren's syndrome.
    Wang X; Bootsma H; Terpstra J; Vissink A; van der Vegt B; Spijkervet FKL; Kroese FGM; Pringle S
    Rheumatology (Oxford); 2020 Oct; 59(10):3003-3013. PubMed ID: 32159757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ESSPRI and other patient-reported indices in patients with primary Sjogren's syndrome during 100 consecutive outpatient visits at one rheumatological clinic.
    Pertovaara M; Korpela M
    Rheumatology (Oxford); 2014 May; 53(5):927-31. PubMed ID: 24464708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of primary Sjögren's syndrome on female sexual function.
    van Nimwegen JF; Arends S; van Zuiden GS; Vissink A; Kroese FG; Bootsma H
    Rheumatology (Oxford); 2015 Jul; 54(7):1286-93. PubMed ID: 25652072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of iguratimod on patients with primary Sjögren's syndrome: a randomized, placebo-controlled clinical trial.
    Shao Q; Wang S; Jiang H; Liu L
    Scand J Rheumatol; 2021 Mar; 50(2):143-152. PubMed ID: 33118847
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence and clinical impact of fibromyalgia in patients with primary Sjögren's syndrome.
    Choi BY; Oh HJ; Lee YJ; Song YW
    Clin Exp Rheumatol; 2016; 34(2 Suppl 96):S9-13. PubMed ID: 26315451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical fatigue characterises patient experience of primary Sjögren's syndrome.
    Arends S; Meiners PM; Moerman RV; Kroese FG; Brouwer E; Spijkervet FK; Vissink A; Bootsma H
    Clin Exp Rheumatol; 2017; 35(2):255-261. PubMed ID: 28032845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.